SpringWorks Therapeutics Inc.
SWTX | NASDAQ
$46.99
$0 (0.00%)
At close: Jul 01, 2025, 04:00 PM ET
Market Data
Market Cap $3.54B
Enterprise Value $3.26B
Beta 0.70
Average Volume N/A
Shares Outstanding (Diluted) 74.89M
Shares Change YoY 1.51%
Institutional Ownership 93.14%
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 1.6%
1Y CAGR (ann.) 24.7%
5Y CAGR (ann.) 1.1%
All-Time CAGR 13.4%
Valuation
PE Ratio -13.78
Forward PE 46.40
PEG Ratio -0.34
Forward PEG 0.04
PS Ratio 16.12
Forward PS 4.20
PB Ratio 8.48
P/FCF Ratio -20.31
P/Adj. FCF Ratio -12.51
P/OCF Ratio -19.83
EV/Sales 14.84
EV/EBIT -12.19
EV/EBITDA -12.44
EV/FCF -18.70
Earnings Yield -7.3%
FCF Yield -4.9%
Adj. FCF Yield -8.0%
Financial Health
Net Cash $287.87M
Total Debt $7.39M
Cash & Short-Term Investments $287.87M
Total Assets $505.36M
Current Ratio 3.81
Quick Ratio 3.70
Debt / Equity Ratio 0.02
Debt / EBITDA -0.03
Debt / FCF -0.04
OCF / Debt -22.38
Interest Coverage 0.00
Altman Z-Score 20.08
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 93.5%
Operating Profit Margin -120.5%
EBITDA Margin -143.4%
Net Profit Margin -134.7%
FCF Margin -79.4%
Adj. FCF Margin -128.8%
SBC / Revenue 57.0%
SBC Impact (per share) -62.3%
Returns
Return on Assets -44.0%
Return on Equity -46.6%
Return on Invested Capital -56.9%
Return on Capital Employed -57.1%
Return on Tangible Assets -45.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 805.4%
Revenue CAGR 5Y 67.5%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 17.7%
EPS CAGR 5Y -13.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y 2.8%
FCF CAGR 5Y -22.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 48.7%
Revenue Growth Next 3Y 68.1%
Earnings Date Aug 5, 2025
EPS Estimate (next Q) -$0.81
EPS Growth Est (next Q) 50.0%
Revenue Est (next Q) $73.39M
Revenue Growth Est (next Q) 22.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $65.40
Price Target Upside 39.2%
Cash Flow
Operating Cash Flow $-165.43M
Free Cash Flow $-174.33M
Adj. Free Cash Flow $-282.96M
FCF Per Share -$2.43
OCF Per Share -$2.37
OCF/S Ratio -91.7%
Income Statement
Revenue $219.67M
Gross Profit $204.8M
Operating Income $-264.74M
EBITDA $-262M
Net Income $-253.93M
EPS (Diluted) -$3.41
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove SWTX